非荷爾蒙避孕市場規模、佔有率和成長分析（按方法、性別、可用性、年齡層、分銷管道、最終用戶和地區分類）—產業預測（2026-2033 年）

預計到 2024 年，全球非荷爾蒙避孕市場規模將達到 326.6 億美元，到 2025 年將成長至 347.9 億美元，到 2033 年將成長至 575.7 億美元，預測期（2026-2033 年）的複合年成長率為 6.5%。

全球非荷爾蒙避孕市場涵蓋多種無需依賴荷爾蒙即可有效阻止受精和著床的方法。主要類別包括屏障法，例如男用和女性用保險套、隔膜和子宮頸帽。這些方法在精子和卵子之間形成物理屏障，其特點是易於取得且副作用極小。此外，基於月經週期的方法，例如基礎體溫監測，利用月經週期追蹤來識別排卵期，但需要精確監測才能有效。非荷爾蒙避孕方法，例如子宮內避孕器（IUD），特別是含銅子宮內避孕器，提供了一種長期解決方案，可以阻止受精並減少日常管理。雖然它們非常有效，但也面臨一些挑戰，例如需要持續使用以及放置過程中可能出現的不適，這凸顯了使用者教育和醫療保健指導對於最大限度地提高其有效性的重要性。

推動全球非荷爾蒙避孕市場發展的因素

推動全球非荷爾蒙避孕市場發展的關鍵因素之一是人們對避孕方法的認知不斷提高。隨著越來越多的人重視計劃生育並尋求安全有效的避孕方法，非荷爾蒙避孕方式的使用率顯著上升。取得教育資源和諮詢服務對於提高消費者對各種避孕方法的了解至關重要，從而增強了他們對非荷爾蒙製劑的偏好。這種需求促使生產者開發創新非荷爾蒙避孕產品，以滿足消費者多樣化的需求，他們越來越傾向選擇符合自身健康偏好和生活方式的產品。

全球非荷爾蒙避孕市場面臨的限制因素

全球非荷爾蒙避孕市場面臨許多挑戰，尤其是在發展中地區，這些地區的避孕途徑和認知度都十分有限。基礎設施和資源的匱乏阻礙了非荷爾蒙避孕方法的廣泛應用，也阻礙了有效避孕的普及。此外，不同社區的文化和宗教信仰也加劇了人們對避孕器的抗拒情緒，進一步阻礙了市場擴張。這些因素不僅導致意外懷孕率上升，也導致性行為感染感染率升高，最終阻礙了非荷爾蒙避孕市場的成長前景。因此，消除這些障礙對於建立一個更強大、更容易獲得的市場至關重要。

全球非荷爾蒙避孕藥市場趨勢

全球非荷爾蒙避孕市場正經歷一個顯著趨勢：消費者對天然有機避孕方案的需求日益成長。隨著消費者對荷爾蒙避孕藥潛在副作用的認知不斷提高，他們正積極尋求不含合成荷爾蒙或化學物質的替代方案。這種轉變推動了非荷爾蒙避孕方法的普及，包括傳統保險套和各種天然計劃生育方法，這些方法被認為更安全、更環保。此外，消費者對永續性和環保意識的日益增強也持續推動著這一趨勢，他們優先考慮符合自身健康和環保價值觀的產品。

目錄

介紹

• 調查目標
• 市場定義和範圍

調查方法

• 調查過程
• 一手和二手資料方法
• 市場規模估算方法
• 市場假設與限制

執行摘要

• 全球市場展望
• 主要市場亮點
• 行業概覽
• 競爭格局概述

市場動態與展望

• 總體經濟指標
• 促進因素和機遇
• 限制與挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場考察

• 關鍵成功因素
• 市場影響指數
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數
• 臨床實驗室分析
• 專利分析
• 用例分析
• PESTEL 分析
• 監管分析
• 管道分析
• 技術分析
• 基礎體溫法使用者

全球非荷爾蒙避孕方法市場（2019-2032 年）

• 屏障法
  • 保險套
  • 男性
  • 女士
  • 子宮托
  • 子宮頸帽
  • 非荷爾蒙子宮內避孕器
  • 避孕海綿
  • 其他設備
• 殺精劑
• 節育手術
  • 男性節育手術（切除術）
  • 無刀輸精管切除術
  • 傳統切除術
  • 微創輸精管切除術
  • 女性節育手術（輸卵管結紮）
  • 腹腔鏡輸卵管結紮術
  • 子宮鏡輸卵管結紮術
  • 微創手術
  • 其他輸卵管手術
• 其他方法

全球非荷爾蒙避孕市場規模（按性別分類）（2019-2032 年）

• 男性
• 女士

全球非荷爾蒙避孕市場規模（依性別分類）及供應情況（2019-2032 年）

• 非處方藥
• 處方箋

全球非荷爾蒙避孕市場按年齡層分類（2019-2032 年）

• 13至19歲
• 20-29歲
• 30-39歲
• 40歲或以上

全球非荷爾蒙避孕市場依通路分類（2019-2032 年）

• 醫院藥房
• 零售藥房
• 線上平台
• 政府和非政府組織分發管道
• 其他

全球非荷爾蒙避孕市場規模（依最終用戶分類）（2019-2032 年）

• 醫院
• 診所
• 門診手術中心
• 其他

全球非荷爾蒙避孕市場規模（2019-2032 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
• 中東和非洲
  • GCC
  • 南非
  • 其他中東和非洲地區

競爭對手儀錶板

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）

主要企業簡介

• Evofem Biosciences
• Dare Bioscience
• CooperSurgical（Cooper Co.）
• Reckitt Benckiser
• Trojan
• Mayer Laboratories Inc.
• LifeStyles Healthcare
• Kessel Medintim GmbH
• Contraline, Inc.
• YourChoice Therapeutics
• Contrel Europe
• NEXT Life Sciences
• Femasys Inc.
• Apothecus Pharmaceutical
• Sebela Pharmaceuticals（Sebela Women's Health）
• FemCap Inc.
• Mona Lisa NV
• Okamoto Industries, Inc.
• Fuji Latex Co., Ltd.
• Veru Inc.

結論和分析師建議

Global Non-Hormonal Contraception Market size was valued at USD 32.66 Billion in 2024 and is poised to grow from USD 34.79 Billion in 2025 to USD 57.57 Billion by 2033, growing at a CAGR of 6.5% during the forecast period (2026-2033).

The global market for non-hormonal contraception encompasses various methods that effectively prevent fertilization or implantation without relying on hormones. Key categories include barrier methods, such as male and female condoms, diaphragms, and cervical caps, which create a physical barrier between sperm and egg and are known for their wide availability and minimal side effects. Additionally, fertility awareness-based methods utilize menstrual cycle tracking to identify fertile windows, requiring precise monitoring for effectiveness. Intrauterine devices (IUDs), specifically non-hormonal types like copper IUDs, offer a long-lasting solution by preventing fertilization and requiring less daily management. Although highly effective, such methods face challenges like the need for consistent use and potential discomfort during insertion, highlighting the importance of user education and healthcare guidance in maximizing their effectiveness.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Non-Hormonal Contraception market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Non-Hormonal Contraception Market Segments Analysis

Global Non-Hormonal Contraception Market is segmented by Method, Gender, Accessibility, Age Group, Distribution Channel, End User and region. Based on Method, the market is segmented into Barrier Method, Spermicidal, Sterilization and Other Methods. Based on Gender, the market is segmented into Male and Female. Based on Accessibility, the market is segmented into Over-the-Counter (OTC) and Prescription-Based. Based on Age Group, the market is segmented into 13-19 Years, 20-29 Years, 30-39 Years and 40+ Years. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Platforms, Government & NGO Distribution Channels and Others. Based on End User, the market is segmented into Hospital, Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Non-Hormonal Contraception Market

A significant factor driving the global non-hormonal contraception market is the rising awareness surrounding contraceptive options. As more individuals prioritize family planning and search for safe and effective methods, there is a notable shift towards non-hormonal alternatives. Access to educational resources and counseling services has played a vital role in enhancing consumer knowledge about various contraceptive methods, leading to an increased preference for non-hormonal solutions. This demand has prompted manufacturers to focus on developing innovative non-hormonal contraceptive products that cater to the diverse needs of consumers, who increasingly seek options that align with their health preferences and lifestyle choices.

Restraints in the Global Non-Hormonal Contraception Market

The global non-hormonal contraception market encounters significant challenges, particularly in developing regions where access and awareness are considerably limited. Inadequate infrastructure and resources restrict the availability of non-hormonal contraceptive options, creating barriers to effective contraception. Furthermore, cultural and religious beliefs in various communities contribute to the reluctance surrounding contraceptive use, further complicating market expansion. These factors not only lead to increased instances of unintended pregnancies but also elevate the rates of sexually transmitted infections, which ultimately stymie the growth prospects for the non-hormonal contraception market. Addressing these obstacles is essential for fostering a more robust and accessible market.

Market Trends of the Global Non-Hormonal Contraception Market

The global non-hormonal contraception market is witnessing a notable trend towards the rising demand for natural and organic contraceptive solutions. As consumers become increasingly educated about the potential adverse effects of hormonal contraceptives, they are actively seeking alternatives that are devoid of synthetic hormones and chemicals. This shift is fostering the popularity of non-hormonal options, including traditional condoms and various natural family planning methods, which are viewed as safer and more environmentally friendly. Furthermore, the growing emphasis on sustainability and eco-consciousness continues to propel this trend, as consumers prioritize products that align with their health and environmental values.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impact Factor
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index
• Clinical Trial Analysis
• Patent Analysis
• Case Study Analysis
• PESTEL Analysis
• Regulatory Analysis
• Pipeline Analysis
• Technology Analysis
• Fertility Awareness Method Users

Global Non-Hormonal Contraception Market Size by Method (Value/Volume) (2019-2032)

• Market Overview
• Barrier Method
  • Condoms
  • Male
  • Female
  • Diaphragms
  • Cervical Caps
  • Non-Hormonal IUDs
  • Contraceptive Sponges
  • Other Devices
• Spermicidal
• Sterilization
  • Male Sterilization (Vasectomy)
  • No-scalpel Vasectomy
  • Conventional Vasectomy
  • Minimally Invasive Vasectomy
  • Female Sterilization (Tubal Ligation)
  • Laparoscopic Tubal Ligation
  • Hysteroscopic Tubal Ligation
  • Mini-Laparotomy
  • Other Tubal Procedures
• Other Methods

Global Non-Hormonal Contraception Market Size by Gender (2019-2032)

• Market Overview
• Male
• Female

Global Non-Hormonal Contraception Market Size by Accessibility (2019-2032)

• Market Overview
• Over-the-Counter (OTC)
• Prescription-Based

Global Non-Hormonal Contraception Market Size by Age Group (2019-2032)

• Market Overview
• 13-19 Years
• 20-29 Years
• 30-39 Years
• 40+ Years

Global Non-Hormonal Contraception Market Size by Distribution Channel (2019-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Platforms
• Government & NGO Distribution Channels
• Others

Global Non-Hormonal Contraception Market Size by End-User (2019-2032)

• Market Overview
• Hospital
• Clinics
• Ambulatory Surgical Centers
• Others

Global Non-Hormonal Contraception Market Size (2019-2032)

• North America (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
  • US
  • Canada
• Europe (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Dashboard

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025

Key Company Profiles

• Evofem Biosciences
  • Company Overview
  • Product Portfolio Overview
  • Financial Overview
  • Key Developments
• The following companies are listed for indicative purposes only. Similar information will be provided for each, with detailed financial data available exclusively for publicly listed companies.
• Dare Bioscience
• CooperSurgical (Cooper Co.)
• Reckitt Benckiser
• Trojan
• Mayer Laboratories Inc.
• LifeStyles Healthcare
• Kessel Medintim GmbH
• Contraline, Inc.
• YourChoice Therapeutics
• Contrel Europe
• NEXT Life Sciences
• Femasys Inc.
• Apothecus Pharmaceutical
• Sebela Pharmaceuticals (Sebela Women's Health)
• FemCap Inc.
• Mona Lisa N.V.
• Okamoto Industries, Inc.
• Fuji Latex Co., Ltd.
• Veru Inc.

Conclusion & Analyst Recommendations